Pharmaceutical Executive: February 2025 Issue (PDF)

Publication
Article
Pharmaceutical ExecutivePharmaceutical Executive: February 2025
Volume 45
Issue 1

Click the title above for a link to open the Pharmaceutical Executive February 2025 issue in an interactive PDF format.

Download Issue PDF
Articles in this issue
Pharmaceutical Executive: February 2025 Issue (PDF)
Pharmaceutical Executive: February 2025 Issue (PDF)
At First Glance
At First Glance
2025 Pipeline Report: The Edge of Greatness?
2025 Pipeline Report: The Edge of Greatness?
Inclusive Marketing: Engaging with Purpose
Inclusive Marketing: Engaging with Purpose
Proactive Engagement: How AI-Driven Alerts are Transforming HCP Outreach
Proactive Engagement: How AI-Driven Alerts are Transforming HCP Outreach
The Shifting Pharmacy Landscape in 2025
The Shifting Pharmacy Landscape in 2025
Navigating the EU’s Joint Clinical Assessment
Navigating the EU’s Joint Clinical Assessment
Biopharma Business Check: Financing Review and Outlook
Biopharma Business Check: Financing Review and Outlook
Statistically and Clinically Significant Paths to Value Proposition
Statistically and Clinically Significant Paths to Value Proposition
AI: Hungry for Power
AI: Hungry for Power
Navigating Cross-Border Pharma Deals: Key Trends and Lessons Out of China
Navigating Cross-Border Pharma Deals: Key Trends and Lessons Out of China
The Teva Turnaround: Steering a Company Comeback
The Teva Turnaround: Steering a Company Comeback
Recent Videos
John Arena
James Foster
John Arena
James Foster
Navigating an Uncertain Regulatory Landscape
James Foster
Related Content
Valencia Technologies Secures Strategic Investment of $35 Million from Brooks Advisory Group, Appoints James D. Surek as CEO

Valencia Technologies Secures Strategic Investment of $35 Million from Brooks Advisory Group, Appoints James D. Surek as CEO

Don Tracy, Associate Editor
February 20th 2025
Article

Valencia will seek to leverage the investment as well as Surek’s leadership experience to drive commercialization of its flagship eCoin system to develop minimally invasive treatments for urinary incontinence.

Navigating Distrust: Pharma in the Age of Social Media

Navigating Distrust: Pharma in the Age of Social Media

Miranda Schmalfuhs
February 18th 2025
Podcast

Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.

Pharma Pulse 2/20/25: Popping the Gross-to-Net Bubble, Prompting Better Care with Question Prompt Lists & more

Pharma Pulse 2/20/25: Popping the Gross-to-Net Bubble, Prompting Better Care with Question Prompt Lists & more

Miranda Schmalfuhs
February 20th 2025
Article

The latest news for pharma industry insiders.

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
February 10th 2025
Podcast

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.

Epitopea Strikes Research Collaboration with Merck, Appoints Klaus Edvardsen as Chief Medical Officer

Epitopea Strikes Research Collaboration with Merck, Appoints Klaus Edvardsen as Chief Medical Officer

Don Tracy, Associate Editor
February 19th 2025
Article

Under terms of the deal, Epitopea and Merck will work to identify Cryptigen tumor-specific antigens through Epitopea’s CryptoMap platform.

Stock.adobe.com

Former Health Agency Heads React to Federal Layoffs at NIH, CDC, and FDA

Mike Hollan
February 19th 2025
Article

Former leaders of the CDC, FDA, and other agencies condemned the layoffs.